Skip to main content

Find Clinical Trials

Home
Conditions
Hyperlipidemia

Clinical trial condition

Hyperlipidemia

Explore clinical trials studying Hyperlipidemia. Study availability and eligibility vary by location and protocol.

341 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Hyperlipidemia trial results

Completed

Survey of Thai-Muslim Health Status

NCT00701454

Conditions: Cardiovascular Diseases, Diabetes, Diabetes Mellitus, +13 more
Locations: Institute of Nutrition, Mahidol University Phuttamonthon, Changwat Nakhon Pathom, Thailand

View Trial Details

Completed

Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function

NCT00654459

Conditions: Dyslipidemias, Endothelial Dysfunction, Hyperlipidemia, +4 more
Locations: Department of internal medicine University Federico II Naples, Italy

View Trial Details

Completed

Metabolism and Body Shape of Healthy Children and Children With Chronic Infections

NCT00001142

Conditions: Blood-Borne Infections, Communicable Diseases, Disease Attributes, +29 more
Locations: National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States

View Trial Details

Completed

The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia

NCT00222833

Conditions: Body Weight, Cardiovascular Diseases, Dyslipidemias, +15 more
Locations: Western Psychiatric Institute and Clinic of UPMC Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease

NCT00134173

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
Locations: Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Mobile, Alabama, United States

Pfizer Investigational Site Little Rock, Arkansas, United States

Pfizer Investigational Site Fresno, California, United States

View all 146 locations

View Trial Details

Completed

A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet

NCT00566267

Conditions: Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.

NCT00267254

Conditions: Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +5 more
Locations: Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Mobile, Alabama, United States

Pfizer Investigational Site Mesa, Arizona, United States

Pfizer Investigational Site Phoenix, Arizona, United States

View all 49 locations

View Trial Details

Completed

Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.

NCT00137462

Conditions: Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations: Pfizer Investigational Site Huntsville, Alabama, United States

Pfizer Investigational Site Union Grove, Alabama, United States

Pfizer Investigational Site Fresno, California, United States

Pfizer Investigational Site Los Angeles, California, United States

View all 59 locations

View Trial Details

Completed

Lipid Lowering in Patients With Statin Intolerance

NCT00405769

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
Locations: Chestnut Hill Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

NCT00139061

Conditions: Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations: Pfizer Investigational Site Angers, France

Pfizer Investigational Site Angers, France

Pfizer Investigational Site Bordeaux Cauderan, France

Pfizer Investigational Site Briollay, France

View all 26 locations

View Trial Details